Literature DB >> 18829388

Type 1 diabetes patients have significantly lower frequency of plasmacytoid dendritic cells in the peripheral blood.

Xueqin Chen1, Levi H C Makala, Yulan Jin, Diane Hopkins, Andy Muir, Nikhil Garge, Robert H Podolsky, Jin-Xiong She.   

Abstract

Dendritic cells uniquely orchestrate the delicate balance between T cell immunity and regulation and an imbalance favoring immunogenic rather than tolerogenic DC is believed to contribute to the development of autoimmune diseases such as type 1 diabetes (T1D). In this study, we determined the frequencies of three blood DC subsets (pDC, mDC1 and mDC2) in 72 T1D patients and 75 normal controls using the Miltenyi blood DC enumeration kit. The frequency of blood pDC was found to be negatively correlated with subject age in both normal controls and T1D patients (p=0.0007), while the frequency of mDC1 and mDC2 do not change significantly with subject age. More importantly, the mean frequency of pDC in blood was, after adjusting for age, significantly lower in T1D (mean=0.127%) than controls (mean=0.188%) (p<6.0 x 10(-5)), whereas no difference was observed for mDC1 and mDC2 between T1D and controls. Furthermore, T1D patients have a lower proportion of pDC and higher proportion of mDC1 among the total blood DC population than normal controls. These results indicate that the frequency of blood pDC and the pDC/mDC1 ratio are negatively associated with T1D.

Entities:  

Mesh:

Year:  2008        PMID: 18829388      PMCID: PMC2602829          DOI: 10.1016/j.clim.2008.08.013

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  34 in total

1.  The nature of the principal type 1 interferon-producing cells in human blood.

Authors:  F P Siegal; N Kadowaki; M Shodell; P A Fitzgerald-Bocarsly; K Shah; S Ho; S Antonenko; Y J Liu
Journal:  Science       Date:  1999-06-11       Impact factor: 47.728

2.  Abnormal peripheral blood dendritic cell populations in type 1 diabetes.

Authors:  Ruihua Peng; Y Li; K Brezner; Sally Litherland; M J Clare-Salzler
Journal:  Ann N Y Acad Sci       Date:  2003-11       Impact factor: 5.691

3.  Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells.

Authors:  Hassen Kared; Annie Masson; Homa Adle-Biassette; Jean-François Bach; Lucienne Chatenoud; Flora Zavala
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

4.  Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes.

Authors:  Shelley Lindley; Colin M Dayan; Amanda Bishop; Bart O Roep; Mark Peakman; Timothy I M Tree
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

5.  Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon.

Authors:  M Cella; D Jarrossay; F Facchetti; O Alebardi; H Nakajima; A Lanzavecchia; M Colonna
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

6.  Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin-dependent diabetes.

Authors:  K Takahashi; M C Honeyman; L C Harrison
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

7.  Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.

Authors:  E Ashley Moseman; Xueqing Liang; Amanda J Dawson; Angela Panoskaltsis-Mortari; Arthur M Krieg; Yong-Jun Liu; Bruce R Blazar; Wei Chen
Journal:  J Immunol       Date:  2004-10-01       Impact factor: 5.422

8.  CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes.

Authors:  E Allison Green; Leonid Gorelik; Catrin M McGregor; Elise H Tran; Richard A Flavell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-29       Impact factor: 11.205

9.  Defective maturation and function of antigen-presenting cells in type 1 diabetes.

Authors:  A Jansen; M van Hagen; H A Drexhage
Journal:  Lancet       Date:  1995-02-25       Impact factor: 79.321

10.  Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus.

Authors:  Ewa Robak; Piotr Smolewski; Anna Wozniacka; Anna Sysa-Jedrzejowska; Henryk Stepień; Tadeusz Robak
Journal:  Eur Cytokine Netw       Date:  2004 Jul-Sep       Impact factor: 2.737

View more
  21 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

2.  Altered Toll-like receptor signaling pathways in human type 1 diabetes.

Authors:  Adam J Meyers; Roopali R Shah; Peter A Gottlieb; Danny Zipris
Journal:  J Mol Med (Berl)       Date:  2010-08-20       Impact factor: 4.599

3.  Age-dependent changes in peripheral blood dendritic cell subsets in normal children and children with specific polysaccharide antibody deficiency (SPAD).

Authors:  Harumi Jyonouchi; Chongwei Cui; Lee Geng; Zhiwei Yin; Patricia Fitzgerald-Bocarsly
Journal:  Eur J Pediatr       Date:  2010-05-15       Impact factor: 3.183

4.  A study of 51 subtypes of peripheral blood immune cells in newly diagnosed young type 1 diabetes patients.

Authors:  A Oras; A Peet; T Giese; V Tillmann; R Uibo
Journal:  Clin Exp Immunol       Date:  2019-06-21       Impact factor: 4.330

5.  A correlation of measles specific antibodies and the number of plasmacytoid dendritic cells is observed after measles vaccination in 9 month old infants.

Authors:  Miguel L García-León; Laura C Bonifaz; Bogart Espinosa-Torres; Brenda Hernández-Pérez; Lino Cardiel-Marmolejo; José I Santos-Preciado; Rosa M Wong-Chew
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

6.  Advances and challenges in biomarker development for type 1 diabetes prediction and prevention using omic technologies.

Authors:  Colleen Carey; Sharad Purohit; Jin-Xiong She
Journal:  Expert Opin Med Diagn       Date:  2010-09-01

7.  Pre-existing autoimmunity determines type 1 diabetes outcome after Flt3-ligand treatment.

Authors:  Tom L Van Belle; Therese Juntti; Jeanette Liao; Matthias G von Herrath
Journal:  J Autoimmun       Date:  2009-12-09       Impact factor: 7.094

8.  Congenic mesenchymal stem cell therapy reverses hyperglycemia in experimental type 1 diabetes.

Authors:  Mollie Jurewicz; Sunmi Yang; Andrea Augello; Jonathan G Godwin; Robert F Moore; Jamil Azzi; Paolo Fiorina; Mark Atkinson; Mohamed H Sayegh; Reza Abdi
Journal:  Diabetes       Date:  2010-09-14       Impact factor: 9.461

9.  Common variable immunodeficiency revisited: normal generation of naturally occurring dendritic cells that respond to Toll-like receptors 7 and 9.

Authors:  E Taraldsrud; B Fevang; P Aukrust; K H Beiske; Y Fløisand; S Frøland; H Rollag; J Olweus
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

Review 10.  Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.

Authors:  A E Barcala Tabarrozzi; C N Castro; R A Dewey; M C Sogayar; L Labriola; M J Perone
Journal:  Clin Exp Immunol       Date:  2013-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.